Department of Medicine 5 – Haematology and Oncology

Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines (2015) Refaian N, Schlereth SL, Koch KR, Notara M, Hos D, Mescher M, Iden S, et al. Journal article Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML (2015) Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Goehring G, et al. Journal article Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia (2015) Ye M, Zhang H, Yang H, Koche R, Staber PB, Cusan M, Levantini E, et al. Journal article Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation (2015) Von Bahr L, Blennow O, Alm J, Bjorklund A, Malmberg KJ, Mougiakakos D, Le Blanc A, et al. Journal article Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV (2015) Saussele S, Krauss MP, Hehlmann R, Lauseker M, Proetel U, Kalmanti L, Hanfstein B, et al. Journal article Delayed therapy with clopidogrel and everolimus prevents progression of transplant arteriosclerosis and impairs humoral alloimmunity in murine aortic allografts (2015) Heim C, Eckl S, Preidl R, Ramsperger-Gleixner M, Koch N, Goldmann K, Spriewald BM, et al. Journal article Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling (2015) Jitschin R, Braun M, Qorraj M, Saul D, Le Blanc K, Zenz T, Mougiakakos D Journal article Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV (2015) Kalmanti L, Saussele S, Lauseker M, Mueller MC, Dietz CT, Heinrich L, Hanfstein B, et al. Journal article What opportunities does Immuno-oncology indicate for overarching long-term survival? (2015) Bergmann L, Brugger W, Herr W, Mackensen A, Multhoff G Journal article Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial (2015) Rollig C, Serve H, Huettmann A, Noppeney R, Mueller-Tidow C, Krug U, Baldus CD, et al. Journal article